• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要蛋白激酶C底物SSeCKS的重新表达可抑制v-src诱导的形态转化和肿瘤发生。

Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.

作者信息

Lin X, Gelman I H

机构信息

Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.

出版信息

Cancer Res. 1997 Jun 1;57(11):2304-12.

PMID:9187136
Abstract

SSeCKS (pronounced essex) encodes a major protein kinase C substrate, the expression of which is down-regulated in src- and ras-transformed rodent fibroblasts but not in raf-transformed rodent fibroblasts (X. Lin et al., Mol. Cell. Biol., 15: 2754-2762, 1995). Using a panel of ras-transformed or revertant Rat-6 cells that exhibit selective parameters of transformation, we show that down-regulation of SSeCKS correlates with anchorage-independent growth. Cotransfection of NIH3T3 fibroblasts with an SSeCKS expression plasmid decreased 6-30-fold the ability of a v-src expressor plasmid to induce colonies in soft agar. To differentiate between possible tumor suppressive or growth-inhibitory effects of SSeCKS, we developed conditionally transformed cell lines (expressing ts72v-src) with tetracycline-regulated SSeCKS expression. SSeCKS suppressed the ability of v-src to induce increased cellular refractility, focus formation, soft agar colony formation, in vitro invasiveness in Matrigel, and growth in low serum (0.5%) but did not inhibit cell proliferation in high serum (10%) at the permissive (35 degrees C) temperature for src kinase activity. However, at the nonpermissive (39.5 degrees C) temperature, SSeCKS induced growth arrest. SSeCKS expression did not affect: (a) the protein level, in vivo or in vitro kinase activity of ts72src; (b) the activity of jun NH2-terminal kinase; and (c) the level of mitogen-activated protein kinase (extracellular signal-regulated kinase 2) protein. However, extracellular signal-regulated kinase 2 activity was induced 5-10-fold by SSeCKS in the presence of active src. SSeCKS reversed the ability of v-src to decrease the formation of vinculin-associated adhesion plaques, actin-based stress fibers, and filopodia structures. These data suggest a tumor suppressive role for SSeCKS via the control of cytoskeletal architecture and cell signaling.

摘要

SSeCKS(发音为埃塞克斯)编码一种主要的蛋白激酶C底物,其在src和ras转化的啮齿动物成纤维细胞中表达下调,但在raf转化的啮齿动物成纤维细胞中未下调(X.林等人,《分子细胞生物学》,15: 2754 - 2762,1995)。使用一组表现出转化选择性参数的ras转化或回复的大鼠6细胞,我们表明SSeCKS的下调与锚定非依赖性生长相关。将SSeCKS表达质粒与NIH3T3成纤维细胞共转染,可使v-src表达质粒在软琼脂中诱导集落的能力降低6 - 30倍。为了区分SSeCKS可能的肿瘤抑制或生长抑制作用,我们构建了四环素调控SSeCKS表达的条件转化细胞系(表达ts72v-src)。SSeCKS抑制v-src诱导细胞折光性增加、焦点形成、软琼脂集落形成、基质胶中的体外侵袭以及在低血清(0.5%)中生长的能力,但在src激酶活性的允许温度(35℃)下不抑制高血清(10%)中的细胞增殖。然而,在非允许温度(39.5℃)下,SSeCKS诱导生长停滞。SSeCKS表达不影响:(a)ts72src的蛋白质水平、体内或体外激酶活性;(b)Jun氨基末端激酶的活性;以及(c)丝裂原活化蛋白激酶(细胞外信号调节激酶2)的蛋白质水平。然而,在有活性src存在的情况下,SSeCKS可使细胞外信号调节激酶2的活性诱导增加5 - 10倍。SSeCKS逆转了v-src降低纽蛋白相关黏附斑、肌动蛋白应力纤维和丝状伪足结构形成的能力。这些数据表明SSeCKS通过控制细胞骨架结构和细胞信号传导发挥肿瘤抑制作用。

相似文献

1
Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.主要蛋白激酶C底物SSeCKS的重新表达可抑制v-src诱导的形态转化和肿瘤发生。
Cancer Res. 1997 Jun 1;57(11):2304-12.
2
Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts.
Oncogene. 2001 Jan 11;20(2):141-6. doi: 10.1038/sj.onc.1204077.
3
The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.Src抑制的C激酶底物SSeCKS是前列腺癌中一种潜在的转移抑制因子。
Cancer Res. 2001 Jul 15;61(14):5644-51.
4
Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS.由src抑制的C激酶底物SSeCKS对细胞骨架结构的调控
Cell Motil Cytoskeleton. 1998;41(1):1-17. doi: 10.1002/(SICI)1097-0169(1998)41:1<1::AID-CM1>3.0.CO;2-J.
5
p60(v-src) and serum control cell shape and apoptosis via distinct pathways in quail neuroretina cells.p60(v-src)和血清通过不同途径控制鹌鹑神经视网膜细胞的细胞形态和凋亡。
Oncogene. 2002 Feb 14;21(8):1171-86. doi: 10.1038/sj.onc.1205170.
6
Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.粘着斑激酶Y397F突变体对v-Src刺激的细胞侵袭和肿瘤生长的差异作用。
J Biomed Sci. 2005;12(4):571-85. doi: 10.1007/s11373-005-7212-5. Epub 2005 Nov 10.
7
SSeCKS gene expression in vascular smooth muscle cells: regulation by angiotensin II and a potential role in the regulation of PAI-1 gene expression.SSeCKS基因在血管平滑肌细胞中的表达:血管紧张素II的调节作用及其在纤溶酶原激活物抑制剂-1(PAI-1)基因表达调控中的潜在作用
J Mol Cell Cardiol. 2000 Dec;32(12):2207-19. doi: 10.1006/jmcc.2000.1246.
8
Tumor necrosis factor-alpha inhibits Schwann cell proliferation by up-regulating Src-suppressed protein kinase C substrate expression.肿瘤坏死因子-α通过上调Src抑制的蛋白激酶C底物表达来抑制雪旺细胞增殖。
J Neurochem. 2009 Nov;111(3):647-55. doi: 10.1111/j.1471-4159.2009.06346.x. Epub 2009 Aug 18.
9
Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenes.在表达ras或src致癌基因的3T3成纤维细胞中p72 - 74 RAF - 1激酶的差异调节。
Cell Growth Differ. 1991 May;2(5):235-43.
10
The oncogenic protein p60v-src has competence activity but does not activate phosphatidylinositol turnover or protein kinase C in Balb/c 3T3 cells.致癌蛋白p60v-src具有转化活性,但在Balb/c 3T3细胞中不激活磷脂酰肌醇代谢或蛋白激酶C。
Oncogene. 1990 Apr;5(4):467-74.

引用本文的文献

1
AKAP12 variant 1 knockout enhances vascular endothelial cell motility.A激酶锚定蛋白12变体1敲除增强血管内皮细胞运动性。
J Vasc Res. 2025 Jul 18:1-24. doi: 10.1159/000547350.
2
The AKAP12-PKA axis regulates lipid homeostasis during alcohol-associated liver disease.AKAP12-PKA轴在酒精性肝病期间调节脂质稳态。
Signal Transduct Target Ther. 2025 Apr 9;10(1):109. doi: 10.1038/s41392-025-02202-1.
3
Protein kinase A and local signaling in cancer.蛋白激酶 A 与癌症中的局部信号转导
Biochem J. 2024 Nov 20;481(22):1659-1677. doi: 10.1042/BCJ20230352.
4
PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.PTEN 调控的 PI3K-p110 和 AKT 同工型可塑性控制转移性前列腺癌的进展。
Oncogene. 2024 Jan;43(1):22-34. doi: 10.1038/s41388-023-02875-4. Epub 2023 Oct 24.
5
Physiologic and pathophysiologic roles of AKAP12.AKAP12 的生理和病理生理学作用。
Sci Prog. 2022 Jul-Sep;105(3):368504221109212. doi: 10.1177/00368504221109212.
6
A-kinase anchoring protein 12 is downregulated in human hepatocellular carcinoma and its deficiency in mice aggravates thioacetamide-induced liver injury.A激酶锚定蛋白12在人类肝细胞癌中表达下调,其在小鼠中的缺失会加重硫代乙酰胺诱导的肝损伤。
Oncol Lett. 2018 Nov;16(5):5907-5915. doi: 10.3892/ol.2018.9396. Epub 2018 Sep 4.
7
Scaffolding during the cell cycle by A-kinase anchoring proteins.细胞周期中由A激酶锚定蛋白构成的支架作用
Pflugers Arch. 2015 Dec;467(12):2401-11. doi: 10.1007/s00424-015-1718-0. Epub 2015 Jul 24.
8
Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients.在耐紫杉醇的浆液性卵巢癌细胞中,AKAP12水平升高具有预后意义,并预示患者生存不良。
J Proteome Res. 2015 Apr 3;14(4):1900-10. doi: 10.1021/pr5012894. Epub 2015 Mar 19.
9
A transgenic mouse model for early prostate metastasis to lymph nodes.一种用于早期前列腺癌淋巴结转移的转基因小鼠模型。
Cancer Res. 2014 Feb 1;74(3):945-53. doi: 10.1158/0008-5472.CAN-13-1157.
10
Gravin is a transitory effector of polo-like kinase 1 during cell division.Gravin 是细胞分裂过程中 polo-like kinase 1 的瞬时效应因子。
Mol Cell. 2012 Nov 30;48(4):547-59. doi: 10.1016/j.molcel.2012.09.002. Epub 2012 Oct 11.